ARCHIVES

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

This article is from The Cancer Letter archive.

Vol. 40 No. 32 | August 8, 2014

Download PDF Visit The Full Archive

Related Articles

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

NIH Revitalization Act Authorizes $3 Billion For NCI In FY97

July 5, 1996

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

June 25, 2010

Budge Act Includes Language On Coverage Of Oral Cancer Drugs

August 13, 1993

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014